60
Participants
Start Date
September 17, 2022
Primary Completion Date
September 30, 2026
Study Completion Date
June 30, 2027
Naltrexone
Participants will receive a single oral dose in randomized, crossover fashion with a 2 week wash out period between interventions. Medication will be taken 2 hours prior the neuroimaging.
Placebo
Participants will receive a single oral dose of medication in randomized, crossover fashion with a 2 week wash out period between interventions.. Medication will be taken 2 hours prior the neuroimaging.
RECRUITING
Children's Mercy Research Institute, Kansas City
University of Kansas Medical Center
OTHER
National Institute of Mental Health (NIMH)
NIH
Children's Mercy Hospital Kansas City
OTHER